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Modulation of autoimmune pathogenesis
by T cell-triggered inflammatory cell death
Katsuhiro Sasaki 1, Ai Himeno1, Tomoko Nakagawa1, Yoshiteru Sasaki1, Hiroshi Kiyonari2 & Kazuhiro Iwai 1
T cell-mediated autoimmunity encompasses diverse immunopathological outcomes; how-
ever, the mechanisms underlying this diversity are largely unknown. Dysfunction of the
tripartite linear ubiquitin chain assembly complex (LUBAC) is associated with distinct
autonomous immune-related diseases. Cpdm mice lacking Sharpin, an accessory subunit of
LUBAC, have innate immune cell-predominant dermatitis triggered by death of LUBAC-
compromised keratinocytes. Here we show that specific gene ablation of Sharpin in mouse
Treg causes phenotypes mimicking cpdm-like inflammation. Mechanistic analyses find that
multiple types of programmed cell death triggered by TNF from tissue-oriented T cells initiate
proinflammatory responses to implicate innate immune-mediated pathogenesis in this T cell-
mediated inflammation. Moreover, additional disruption of the Hoip locus encoding the
catalytic subunit of LUBAC converts cpdm-like dermatitis to T cell-predominant autoimmune
lesions; however, innate immune-mediated pathogenesis still remains. These findings show
that T cell-mediated killing and sequential autoinflammation are common and crucial for
pathogenic diversity during T cell-mediated autoimmune responses.
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The linear ubiquitin chain assembly complex (LUBAC) is atripartite enzyme comprising Sharpin, HOIL-1L, and cat-alytic HOIP; its dysfunction is closely associated with
autoinflammatory syndrome and immune deficiency in humans
and mice1–3. LUBAC conjugates linear-type ubiquitin chains on
target substrates, such as NF-κB essential modulator (NEMO)
and receptor-interacting serine/threonine protein kinase 1
(RIPK1), to activate NF-κB signaling in response to exogenous
triggers such as TNFα, IL-1β, and T cell receptor (TCR) stimu-
lation4–8. Upon TNFα signaling, the ligase activity of LUBAC is
requisite for protection against two types of programmed cell
death, apoptosis and necroptosis; the latter is induced by gen-
eration of cytosolic death-inducible complex II comprising
RIPK1, RIPK3, FAS-associated death domain protein (FADD),
cellular FLICE (FADD-like IL-1β-converting enzyme)-inhibitory
protein (cFLIP), and Caspase-89,10. LUBAC subunits contribute
differentially to the stability of the complex. Deletion of Hoip or
Hoil-1l in mice, which eliminates the LUBAC complex, results in
embryonic lethality due to aberrant TNFR1-mediated endothelial
cell death and defective vascularization10,11, whereas spontaneous
mutant mice lacking Sharpin (called cpdm mice) are viable but
develop chronic skin autoinflammation, which is triggered by
death of keratinocytes4,12–14.
In humans, autoinflammation is a self-directed immune dis-
order that manifests as chronic and recurrent inflammation. In
most cases, it has a genetic etiology, leading to dysregulation of
innate, but not adaptive, immune responses; this causes over-
production of proinflammatory cytokines such as IL-1β and
TNFα, or exaggerated responsiveness to a steady-state level of
stimulation by proinflammatory cytokines that may trigger
release of other endogenous stimuli, including damage-associated
molecular patterns (DAMPs), to aggravate innate immune-
related inflammation15,16. Thus, autoinflammation is defined by
various forms of myeloid cell-mediated systemic inflammation,
without classical autoimmune characteristics such as high-titer
autoantibodies or the presence of self-reactive T cells. Other
studies suggest that cpdm mice manifest additional features.
Studies of cpdm Rag1−/− mice and cpdm-derived bone marrow
cell transfer experiments suggest that hematopoietic cells,
including T cells and B cells, are dispensable for development of
cpdm skin disease17,18. Furthermore, Sharpin-deficient skin
transplanted onto nude mice develops autonomous inflammatory
responses that clearly indicate that keratinocytes showing hypo-
morphic LUBAC expression are susceptible to autonomous cell
death mediated by FADD-caspase-8-dependent apoptosis and
RIPK1-RIPK3-mixed-lineage kinase domain-like protein
(MLKL)-dependent necroptosis, resulting in autoinflammation
even under steady-state conditions19.
Nevertheless, recent studies imply the presence of autoimmune
aspects in LUBAC hypomorphic disease: cpdm mice show
impaired development and a reduced number of Foxp3+ reg-
ulatory T cells (Treg), a critical T cell subset for immunosup-
pression. In addition, adaptive transfer of Sharpin-sufficient Treg
into neonatal cpdm mice alleviates inflammatory responses in
various tissues, but does not improve dermatitis20,21. These
reports imply that cpdm mice suffer from both autoimmune and
autoinflammatory diseases, although they exhibit predominantly
innate immune-mediated inflammation. Here, we examine the
possibility that T cell-induced inflammation elicits an apparently
innate immune-mediated pathogenesis, as observed in cpdm
disease.
Results
Loss of Sharpin in Treg causes cpdm-like skin inflammation.
To examine the pathogenic potency provoked by loss of Sharpin
in Treg, we generated Treg-specific Sharpin-deficient mice
(Sharpinfl/flFoxp3Cre). Expression of Sharpin by CD4+Foxp3+ Treg
purified from the peripheral lymphoid tissues of Sharpinfl/flFoxp3Cre
mice was completely abolished, whereas that of HOIP fell, indi-
cating a profound reduction in the amount of LUBAC complex
(Fig. 1a, Supplementary Fig. 1A). However, Sharpinfl/flFoxp3Cre
mice exhibited few changes in the number and proportion of
Foxp3+ thymocytes and peripheral Treg (Fig. 1b, Supplementary
Fig. 1B). Partial impairment of the NF-κB signaling pathway in
Sharpin-deficient Treg was demonstrated by a reduction in p65
phosphorylation on Ser536 and subtle inhibition of IκBα degra-
dation during TCR stimulation; however, the TCR-mediated ERK
signaling pathway was unaffected (Fig. 1c). The cell-intrinsic roles
of Sharpin in T cells were confirmed in Sharpin-KO and HOIP-
KO Jurkat or murine hybridoma cells. HOIP-KO Jurkat cells lost
the ability to activate NF-κB signaling in response to TCR sti-
mulation, whereas Sharpin-KO cells still retained this signaling
pathway, albeit mildly impaired (Supplementary Fig. 1C, D).
OVA agonistic peptide (SIINFEKL)-driven secretion of IL-2 from
a murine OVA-specific B3Z T cell hybridoma upon loss of either
HOIP or Sharpin was attenuated, which indicated marked
involvement of LUBAC subunits in TCR-mediated signaling
(Supplementary Fig. 1E). Furthermore, introduction of HOIP
mutants into HOIP-KO Jurkat cells revealed that the UBA
domain, which is required for stable HOIP expression via inter-
action with the other LUBAC subunits (Sharpin and HOIL-1L) in
various cells, was also critical in T cells. In addition, the novel zinc
finger (NZF) domain of HOIP appeared essential due to its strong
binding to polyubiquitin chains and/or NEMO. LUBAC ligase
activity was dispensable for TCR-mediated NF-κB signaling since
HOIP C885S (which lacks ligase activity) induced TCR- but not
TNFα-mediated activation of NF-κB (Supplementary Fig. 1F, G)
22. Thus, it is likely that the amount of LUBAC containing HOIP,
but neither ligase activity nor composition of the complex, is the
critical factor for TCR-mediated T cell activation (Supplementary
Fig. 1G).
Treg from Sharpinfl/flFoxp3Cre mice showed normal expression
of Treg functional surface markers and stabilization markers for
thymic Treg (Supplementary Fig. 1H, I), indicating that the trace
amount of LUBAC (composed of HOIP and HOIL-1L) present in
Sharpin-deficient cells is sufficient to elicit signaling for thymic
Treg development despite mild impairment of TCR signaling.
However, global gene expression between Sharpin-deleted Treg
and control Treg was different (63 [<two-fold] and 84 [>two-
fold] out of 21,178 detected genes). Expression of genes encoding
effector Treg signatures such as CD83, Pdcd1, Bcl6, Tnfrsf9, Irf4,
Egr2, Cxcl10, and IL1r2, TCR-inducing molecules such as Nrn1,
Slc7a10, Tnfsf11, CD38, Nt5e, and Plagl1, and homing receptors
Ccr4, Ccr6, and Ccr9 was downregulated in Sharpin-deficient
Treg (Fig. 1d). Furthermore, phenotypic analyses revealed that
the percentage of effector Treg (CD44hiCD62Llo, CCR6+, or
Ki67+) in the spleen and pLNs fell (Fig. 1e–g). In vivo co-transfer
experiments using both naïve T cells and Treg revealed that
Sharpin-deficient Treg failed to prevent recipient mice from
developing T cell-dependent colitis and colitis-induced weight
loss (Supplementary Fig. 1J). These data indicate that a sufficient
amount of LUBAC is necessary to elicit signals that induce
differentiation into an effector Treg phenotype and signals that
regulate Treg-mediated immune responses.
Sharpinfl/flFoxp3Cre mice succumbed to chronic skin inflam-
mation at around 4 weeks of age, and survived for at least
5 months (Fig. 1h). The skin lesions displayed autoinflammatory
aspects similar to those observed in cpdm mice, which is a model
of autoinflammatory dermatitis that shows hyperkeratosis,
parakeratosis, keratinocyte apoptosis, lamellar fibrosis, and
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dermal infiltration by granulocytes (Fig. 1i). Histological analyses
also revealed limited inflammation in the lungs, but the other
tissues were normal (Supplementary Fig. 1K). They had
lymphadenopathy, with marked influx of CD3+ T cells, B220+
B cells, and CD11b+ myeloid cells (Supplementary Fig. 1L, M).
Thus, these results demonstrate that intrinsic loss of Sharpin
impairs the immunosuppressive function of Treg by inhibiting
differentiation into effector Treg, resulting primarily in chronic
cpdm-like skin inflammation.
T cells drive skin autoinflammation in cpdm mice. Next, we
generated Sharpinfl/flLckCre mice that do not express Sharpin in
most T cell lineages, including Treg and proinflammatory and
cytotoxic T cells. A majority of Sharpinfl/flLckCre mice exhibited
no overt symptoms and survived normally, although around 12%
suffered from dermatitis with generalized lymphadenopathy
(Fig. 2a, b, Supplementary Fig. 2A). Other tissues appeared nor-
mal. Peripheral T cell lineages in healthy Sharpinfl/flLckCre mice
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activated (CD44hiCD62Lhi/lo or CD69hi) phenotypes (Fig. 2c, d,
Supplementary Fig. 2B–D). To probe defects in T cell immune
responses in Sharpinfl/flLckCre mice, we stimulated purified T cells
in vitro. During the early phase of T cell activation, subtle inhi-
bition of IκBα degradation was detected in Sharpin-deficient
T cells, although expression of Nur77, an intermediate-early gene
involved in TCR signaling, was comparable. In addition, at the
late phase of activation we observed marked inhibition of CD25
and CD69 expression on the cell surface (Fig. 2g). Furthermore,
an in vivo T cell cytotoxic assay revealed that Sharpin-deficient
T cells induced T cell-mediated colitis and resultant weight loss
(Fig. 2h, i); however, they had a lower pathogenic potency and
exhibited a lower percentage of activated CD25+ T cells in the
mesenteric lymph nodes (Fig. 2h, j). We also found that depletion
of B cells or Gr1+ myeloid cells did not affect on the skin disease
of Sharpinfl/flFoxp3Cre mice (Supplementary Fig. 2E). Considering
that development of autoimmune diseases depends largely on the
immunological balance between self-reactive T cells and immu-
nosuppressive Treg, these data suggest that the cpdm-like skin
inflammation observed in Sharpinfl/flFoxp3Cre mice is triggered,
in some way, by T cell-mediated autoimmune pathogenesis.
Furthermore, to examine involvement of T cells in autoin-
flammatory skin pathogenesis in cpdm mice, we adapted a
conditional expression system to express Sharpin along with
EGFP (under control of the endogenous ROSA26 promoter) in a
Cre recombinase-dependent manner. We then generated geneti-
cally engineered cpdm mice in which Sharpin was specifically re-
expressed in Treg or the Lck+ T cell lineage (cpdm R26-Sharpin;
Foxp3Cre or cpdm R26-Sharpin;LckCre, respectively) (Supplemen-
tary Fig. 3A). Recovered expression of Sharpin in these cells
was detected by immunoblot or flow cytometry analysis
(Supplementary Fig. 3B–D). Consistent with our findings in
Sharpinfl/flFoxp3Cre and Sharpinfl/flLckCre mice, introduction of
Sharpin into Treg delayed onset of dermatitis until after 3 months
of age and did not induce growth disturbance (Fig. 3a, b).
Histological analyses revealed suppressed epidermal hyperplasia
and TUNEL-positive apoptotic cell death in the skin of cpdm
R26-Sharpin;Foxp3Cre and cpdm R26-Sharpin;LckCre mice (Fig.
3c, d). The ameliorated skin inflammation led to marked
suppression of autoinflammation-related cytokines such as TNFα,
IL-1β, and IL-6, which were elevated in cpdm skin; similar
observations were made with respect to development of
immunopathological hallmarks of cpdm disease, such as spleno-
megaly and infiltration of multiple organs by myeloid cells (Fig.
3e–g and Supplementary Fig. 3E). In addition, the previously
reported decrease in the Treg population in cpdm mice improved
in these mice (Fig. 3h). These results indicate that normalization
of T cell-mediated immunological functions improves skin
autoinflammation in cpdm mice, and demonstrate that T cell-
related mechanisms appear to play critical roles in multiple
pathogeneses underlying skin autoinflammation of cpdm mice.
Autoinflammation extrinsically downregulates Foxp3 in Treg.
In contrast to Sharpinfl/flFoxp3Cre mice, cpdm mice harbored a
significantly lower population of peripheral Treg (Supplemen-
tary Fig. 4A)20,21. Since inflammation reduced expression of
Foxp3 in Treg, we generated TNFα−/− cpdm mice to suppress
progression of dermatitis. Suppression of TNFα-mediated
dermatitis led to marked rescue of Foxp3 expression in Treg,
indicating that reducing the Foxp3+ T cell population in cpdm
mice was a secondary effect with respect to chronic dermatitis
(Supplementary Fig. 4B). Furthermore, keratinocyte-specific
Sharpin-deficient mice (Sharpinfl/flK5Cre) developed cpdm-like
dermatitis, suggesting that Sharpin expression by keratinocytes
is requisite for tissue integrity, at least through inhibition of
keratinocyte cell death (Supplementary Fig. 4C, D). Onset of
the skin disease was independent on the presense of lympho-
cytes, but required for TNFα expression (Supplementary Fig 4I,
J). Sharpinfl/flK5Cre mice also displayed liver inflammation
albeit to a lesser extent; however, other tissues were normal.
Although Treg from Sharpinfl/flK5Cre mice were genetically
intact, they displayed reduced expression of Foxp3 and shifted
to an activated and short-lived phenotype as dermatitis pro-
gressed (Supplementary Fig. 4E–G). In addition, experiments
with thymic epithelial cell (TEC)-specific Sharpin-deficient
mice (Sharpinfl/flβ5tCre) revealed that expression of Sharpin in
Keratin5+ TECs was irrelevant with respect to Treg instability
and development of dermatitis (Supplementary Fig. 4H). Col-
lectively, these data indicate that chronic autoinflammation
induced by keratinocyte cell death causes extrinsic suppression
of Foxp3 in Treg that possibly elicited the previously reported
autoimmune aspects of cpdm mice by augmenting the functions
of effector T cells.
Similar disease outcomes in Sharpinfl/flFoxp3Cre and K5Cre.
Involvement of T cells in development of cpdm-like skin disease
in Sharpinfl/flFoxp3Cre mice seems contradictory to the
current concept of autoinflammatory disease. To compare
immunopathological changes in Sharpinfl/flFoxp3Cre with those in
classical autoinflammatory disease, we used Sharpinfl/flK5Cre
mice in which augmented susceptibility to TNFα-induced kera-
tinocyte cell death underlies dermatitis. The skin lesions in
Sharpinfl/flK5Cre mice resembled those in cpdm, including infil-
tration by F4/80+ macrophages and MPO+ granulocytes, but not
lymphocytes (including T cells), which seems consistent with
the context of autoinflammation (Fig. 4a). Next, we performed
a detailed comparison of the immunological phenotypes of
Sharpinfl/flK5Cre and Sharpinfl/flFoxp3Cre mice. Despite the T cell-
mediated skin inflammation in Sharpinfl/flFoxp3Cre mice, the skin
lesions were infiltrated predominantly by myeloid cells (Fig. 4a,
b). Both strains suffered from eosinophilia and neutrophilia, as
defined by an increase in CD11b+SiglecF+ and CD11b+Gr1hi
cells, respectively, in the spleen (Fig. 4c). Moreover, expression of
Fig. 1 Sharpin deficiency in Treg causes cpdm-like skin inflammation. a Western blot analysis of LUBAC components from sorted CD4+CD25+Foxp3+
Treg. Actin is indicated as a loading control. Asterisks indicate non-specific bands. b Percentage of Foxp3+CD25+ Treg within the CD4+ T cell population,
absolute cell number of Treg, and the mean fluorescent intensity (MFI) of Foxp3 in Treg in the spleen and peripheral LNs (pLNs) from 10-week-old mice.
n= 5 biologically independent animals. c MFI of signal mediators in Treg upon CD3/28 antibody-based activation. Intracellular staining was performed.
Data for p-p65 or IκBα/p-ERK were acquired 5 and 10min after activation, respectively. n= 6 biologically independent animals. d Expression of selected
genes associated with Treg function and TCR-inducible Treg markers is presented in heat maps. Data are derived from three independent experiments.
e Representative plots and percentage of effector (eTreg; CD44hiCD62Llo) and central (cTreg; CD44loCD62Lhi) Treg subsets in the spleen and pLNs. n= 4
biologically independent animals. f Percentage of CCR6+ effector Treg subsets. n= 9 biologically independent animals. g Percentage of Ki67+ Treg subsets.
n= 5 biologically independent animals. h Appearance of skin inflammation at 10 weeks old. i Representative photos of H/E-stained skin of Sharpinfl/
flFoxp3Cre, control, and cpdm mice. Scale bar: 200 μm. Small circles in the graphs indicate data from an individual mouse. Small horizontal lines indicate the
mean (±s.e.m.). ns, p > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. Two-tailed Mann–Whitney U-test was used for b, c, and e–g. Data are
pooled from at least three independent experiments (b, c, e–g). Also, see Supplementary Fig. 1. Source data are provided in a Source Data file
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proinflammatory (IL-6, TNFα, and IL-1β) and allergy-related
(TSLP) cytokines was very similar in Sharpinfl/flFoxp3Cre and
Sharpinfl/flK5Cre mice (Fig. 4d). However, there were some dif-
ferences between Sharpinfl/flFoxp3Cre and Sharpinfl/flK5Cre mice
based on etiology. Peripheral granulocytes in Sharpinfl/flK5Cre, but
not Sharpinfl/flFoxp3Cre, mice showed increased IL-6-mediated
STAT3 phosphorylation, which is indicative of cytokine-
dominant autoinflammatory traits (Fig. 4e). By contrast, Shar-
pinfl/flFoxp3Cre, but not Sharpinfl/flK5Cre, mice exhibited increased
numbers of self-reactive CD69+ T cells in peripheral tissues and
the presence of skin-reactive autoantibodies in serum (Fig. 4f, g).
In addition, only Sharpinfl/flFoxp3Cre mice showed distinct dif-
ferences in progression of skin disease severity between males and
females (gender-specific differences in severity are a common
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Fig. 2 Sharpin predisposes mice to spontaneous T cell-dependent dermatitis. a Representative appearance of 12-week-old control, healthy, and sick
Sharpinfl/flLckCre (left) mice and photos of H/E-stained skin (right). Scale bar: 200 μm. b Incidence of spontaneous dermatitis. All mice were monitored over
a period of 6 months. c Percentage of effector CD44hiCD62Llo or memory CD44hiCD62Lhi subsets within the CD4+ or CD8+ T cell populations in the
spleen and pLNs from 12-week-old healthy Sharpinfl/flLckCre mice. n= 6 biological independent animals. d Percentage of recently activated CD69+ cells
within the CD8 T cell population in pLNs. n= 4 biological independent animals. e MFI of IκBα in T cells at 10 min after CD3/28 antibody-based TCR
stimulation. Intracellular staining was performed. n= 6 biological independent animals. f MFI of Nur77 in T cells at 3 h after CD3 or CD3/CD28 antibody-
based TCR stimulation. n= 3 biological independent animals. g CD69 and CD25 expression by CD4+ or CD8+ T cells at the indicated times after TCR
stimulation. h Experimental induction of colitis by naïve CD4+ T cells. Rag2−/− mice were intravenously injected with HBSS alone or with 2.5 × 105 sorted
naïve CD4+ T cells (CD45RBhiCD25−CD4+CD3ε+), which were obtained from pooled cells isolated from the spleen and pLNs of 4-week-old mice.
Bodyweight of injected Rag2−/− mice was monitored twice or thrice weekly. Data indicate average values. i Representative photos of H/E and
immunofluorescent staining against CD3+ T cells within the inflamed colon of mice in h. j Percentage of CD25+CD4 T cells in the mesenteric LN (mLN) of
mice in h. n= 4 biological independent animals. Small horizontal lines indicate the mean (±s.e.m.). ns, p > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001.
Kruskal–Wallis test with Bonferroni correction (α value= 0.05) was used for h, while two-tailed Mann–Whitney U-test was used for c–f and j. Data are
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Fig. 3 Genetic compensation of Sharpin in T lineages rescues cpdm mice from autoinflammatory skin disease. a Representative appearance of 10-week-old
cpdm and cpdm R26-Sharpin;Foxp3Cre mice. b Body weight of indicated 10–12-week-old mice. n= 4 biologically independent animals. c, d Representative skin
sections from the indicated 12-week-old mice. Scale bars: 200 μm for H/E (c) and 50 μm for TUNEL staining (d). TUNEL-positive epidermal cells are
indicated as arrowheads. e Quantitative analyses of mRNAs encoding inflammation-related cytokines in the skin of 10–12-week-old mice. f Spleen weight
from the indicated 10–12-week-old mice. n= 7 biologically independent animals. g Absolute number of eosinophils (CD11b+Gr1+SiglecF+) and neutrophils
(CD11b+Gr1hi) in the spleen (upper) and liver (lower). n= 6 biologically independent animals. h Absolute number and percentage of Treg, and MFI of
Foxp3 in Treg, in the spleen and liver of 10–12-week-old mice. n= 5 biologically independent animals. Data are representative of two independent
experiments (c, d) or pooled from three independent experiments (b, e–h). Small circles indicate individual mice. Small horizontal lines indicate the mean
(± s.e.m.). *p < 0.05, **p < 0.01, ***p < 0.001. Kruskal-Wallis test with Bonferroni correction (α value= 0.05) was used for b, e–h. Also, see Supplementary
Fig. 3. Source data are provided in a Source Data file
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characteristic of autoimmune diseases) (Fig. 4h). Thus, the data
indicate that T cell-induced autoinflammation is a main patho-
genesis underlying T cell-elicited immunological changes in
Sharpinfl/flFoxp3Cre mice. However, the comparable skin pathol-
ogies suggest that pathological changes in Sharpinfl/flFoxp3Cre
mice are provoked in a manner similar to those in autoin-
flammatory Sharpinfl/flK5Cre mice.
Skin-oriented T cells induce programmed keratinocyte death.
Next, we examined autoinflammatory manifestations in
Sharpinfl/flFoxp3Cre mice in more detail. Keratinocyte death is a
critical event that triggers autoinflammation in cpdm mice
since LUBAC protects against TNFα-induced caspase-depen-
dent apoptosis and necroptosis; the latter is a type of pro-
grammed necrotic cell death mediated by RIPK1, RIPK3, and
MLKL23. Immunohistochemical staining of cleaved caspase-3
(apoptosis) or phosphorylated MLKL (necroptosis) confirmed
that both types of cell death occur in keratinocytes in the
inflamed skin of Sharpinfl/flK5Cre mice (Fig. 5a, b). To our great
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of Sharpinfl/flFoxp3Cre mice; indeed, the phenomena were
almost as common in these mice as in Sharpinfl/flK5Cre mice
(Fig. 5a, b). Additional elimination of Sharpin from Treg in
Sharpinfl/flK5Cre mice (Sharpinfl/flK5CreFoxp3Cre) exacerbated
skin inflammation, with a marked increase in caspase-3 activity
in CD45neg keratinocytes, which led to earlier onset of disease
(Fig. 5c–e). Moreover, a massive T cell infiltrate was observed
in the skin of Sharpinfl/flK5CreFoxp3Cre mice (Fig. 5f). Collec-
tively, these results strongly suggest that skin-oriented acti-
vated T cells promote keratinocyte death and induce skin
autoinflammation, and that induction of cell death underlies T
cell-mediated inflammatory processes.
Fig. 4 Distinct etiologies, autoimmunity in Sharpinfl/flFoxp3Cre or autoinflammation in Sharpinfl/flK5Cre, result in similar myeloid cell-dominant inflammatory
outcomes. a Pathology underlying skin inflammation. Skin sections were subjected to Masson’s trichrome and immunofluorescence staining. The types of
infiltrating immune cell were identified by staining with antibodies specific for CD3ε (T cells), F4/80 (macrophages), and MPO (neutrophils). Keratin14
(K14) was used as a structural marker of the epidermis. The outlined areas are magnified in Fig. 7f. Scale bars: 100 μm. b Percentage of skin-infiltrating
CD11b+ cells. c Representative plots, percentages, and absolute numbers of eosinophils (CD11b+SiglecF+) and neutrophils (CD11b+Gr1hi) in the spleen in
6-week-old Sharpinfl/flK5Cre and 10-week-old Sharpinfl/flFoxp3Cre and respective control mice. n= 5 biologically independent animals. d Quantitative analysis
of skin mRNA encoding inflammation-related cytokines. n= 4 biologically independent animals. e Histogram showing the presence of phosphorylated
STAT3 in Gr1+ granulocytes isolated from secondary lymph nodes. As a positive control, cells were incubated for 15 min at 37 °C with IL-6 (30 ng/ml)
prior to intracellular staining. f Percentage of activated CD69+ subsets in CD4+ or CD8+ T cells in secondary lymphoid tissues. n= 5 biologically
independent animals. g Detection of skin-associated autoantibodies in serum. Scale bars: 100 μm. h Severity scores for spontaneous skin inflammation.
Each score represents an average value from the indicated number of mice. Small horizontal lines indicate the mean (±s.e.m.). ns, p > 0.05; *p < 0.05; **p <
0.01. Two-tailed Mann–Whitney U-test was used for c–f. Data are representative of at least three independent experiments (a, b, e, g), or pooled from two




























































































































































Fig. 5 Skin-oriented T cells induce apoptotic and necroptotic keratinocyte death in an inflammatory setting. a TUNEL staining of skin sections from 5-week-
old Sharpinfl/flK5Cre, 10-week-old Sharpinfl/flFoxp3Cre, and control mice. Scale bars: 50 μm. b Immunofluorescence staining of skin sections. Cleaved caspase-
3 and phosphorylated MLKL were used as markers of apoptosis and necroptosis, respectively. Scale bars: 20 μm. Cell death in the epidermis was quantified
by counting the total number of bright cells per low-power field (LPF). c Appearance of skin dermatitis. d Progression (upper) and incidence (lower) of skin
disease among the indicated strains (numbers of mice: control, n= 12; Sharpinfl/flK5Cre, n= 15; Sharpinfl/flK5CreFoxp3Cre, n= 8). Disease scores were
recorded up to 60 days after birth. No gender-based differences in the incidence of skin disease were observed. e Representative histogram showing death-
prone epidermal cells from the indicated strains. Isolated epidermal cells were incubated with PhiPhiLux-G1D2, a fluorescent substrate of active caspase-3.
f Immunofluorescence staining of skin sections to detect skin-infiltrating T cells. Scale bars: 100 μm. The small horizontal lines in b, d indicate the mean
(±s.e.m.). Data are representative of at least three independent experiments. Source data are provided in a Source Data file
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Fig. 6 A pathogenic role of the TNFα-TNFRI axis during T cell-mediated autoinflammation. a Staining of MEFs co-cultured with T cells. Scale bars: 100 μm.
Magnified images are shown on the right. b–d Percentage of surviving cells in a (b), Sharpin−/− MEFs co-cultured with the indicated T cells (c), and the
indicated CRISPR/Cas9-targeted MEFs (d) n= 4 biologically independent experiments. e Treatment with a TNFα-neutralizing antibody or solubilized
TNFRII. f Treatment with z-VAD-fmk and/or Nec1. The iCelligence system was used to measure cell viability. g, h Survival after 10 h of the treatment
described in f (g) or after siRNA knockdown (h). n= 4 independent experiments. i Expression of the indicated receptors on the T cell surface after TCR
stimulation. j Disease progression among the indicated strains. M, Male; F, Female. k Immunofluorescence staining of skin sections. Scale bars: 20 μm.
l Ratio of CD3εintTCRβ+:CD3εhiTCRγδ+ cells. n= 6 biologically independent animals. m Number of TCRβ+ T cells in the skin. n= 4 biologically
independent animals. n Percentage of TNFα- and/or IFNγ-expressing TCRβ+ T cells in the skin. n= 4 biologically independent animals. o Dot plots
representing TRM cells. p, q MFI or percentage of cells expressing the indicated surface proteins. n= 8 biologically independent animals. Small horizontal
lines indicate the mean (±s.e.m.). *p < 0.05, **p < 0.01, ***p < 0.001. Kruskal–Wallis test with Bonferroni correction (α value= 0.05) was used for b–d, g,
and h, while two-tailed Mann–Whitney U-test was used for l–n, p, and q. Data are representative of at least two independent experiments (a, f, i, k, o), or
pooled from three to six (b–e, g, h, l–n, p, q) independent experiments. Source data are provided in a Source Data file
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TNFα-TNFRI axis implicates T cell-triggered autoinflamma-
tion. To examine the molecular mechanisms underscoring T
cell-mediated autoinflammation, we set up co-culture experi-
ments with primary T cells as effectors and fibroblasts as targets.
In these experiments, 40–50% of LUBAC-compromised MEFs
died within 10 h (Fig. 6a, b). Cell death was not restricted by
MHC because both isolated CD4+ and CD8+ T cells induced
death at comparable levels. Instead, deletion of Tnfrsf1a genes
encoding TNFRI, but not β2m or Tap1, protected target cells
from death (Fig. 6c, d). Furthermore, a TNFα-neutralizing
antibody (XT3.11) and a soluble Fc-fused TNFRII protein
(etanercept) inhibited T cell-dependent cell death in a dose-
dependent manner (Fig. 6e). TNFα is a well-known inducer of
apoptosis and/or necroptosis under certain conditions24,25. The
pan-caspase inhibitor z-VAD-fmk (z-VAD) and the RIPK1
kinase inhibitor Necrostatin-1 (Nec1) inhibit apoptosis and
necroptosis, respectively. Treatment with z-VAD alone sensi-
tized MEFs to necroptosis, whereas concomitant treatment with
both z-VAD and Nec1 rescued them from death almost com-
pletely, even in long-term co-culture (Fig. 6f, g). These data were
confirmed by the observation that target cells treated with
siRNA targeting the necroptosis regulator RIPK3, but not
apoptosis regulators such as caspase-8 or FADD, showed
improved survival (Fig. 6h). Moreover, considering that the
unstimulated T cells used herein showed only weak expression
of TNFα, and that expression increased preferentially in most
T cells after TCR stimulation (Fig. 6i), we anticipated that TNFα
would be an exacerbating factor for T cell-related inflammatory
diseases. Therefore, to determine whether TNFα-induced pro-
grammed cell death plays a role in the autoinflammatory-like
pathogenesis in Sharpinfl/flFoxp3Cre mice, we generated Shar-
pinfl/flFoxp3Cre mice lacking TNFα or RIPK3. We found that
both mouse strains showed clear amelioration of skin disease
progression with restricted occurrence of programmed cell death
(Fig. 6j, k). Indeed, the number of TCRβ+, but not TCRγδ+,
T cells in the skin of Sharpinfl/flFoxp3Cre mice was more than 10-
fold higher than that in control mice, and skin TCRβ+ cells
expressed much more TNFα and IFNγ, although they were a
minor component of the skin infiltrate (Fig. 6l–n). It was
interesting that most of the skin-infiltrating T cells appeared to
have a CD103+CD69+CD62Llo resident memory T (TRM)
phenotype because TRM cells reside long-term and function
protectively in the skin (Fig. 6o)26,27. Consistent with the results
of in vitro T cell cytotoxicity studies, the TNFα-TNFRI axis,
rather than other necroptosis-inducible death signaling path-
ways via DR5 or Fas receptor, appeared primarily to drive
keratinocyte cell death in Sharpinfl/flFoxp3Cre mice (Fig. 6p).
Furthermore, we observed upregulated expression of TNFRII
and CD40, a receptor for T cell activation co-stimulator CD40L,
on keratinocytes (Fig. 6p, q)28–31. Thus, these in vivo and
in vitro experiments confirm the pathogenicity of multiple types
of T cell-mediated programmed cell death and reveal the
underlying role of the TNFα-TNFR1 axis during skin
autoinflammation.
T cell-triggered cell death modulates autoimmune outcomes.
We clarified that Treg-specific ablation of Sharpin preferentially
induces T cell-mediated autoinflammation, whereas loss of
Hoip from Treg, in which the LUBAC complex no longer
exists, causes a fatal multi-organ inflammatory response that
closely resembles the pathology in Foxp3-lacking Scurfy mice, a
classical model of autoimmune disease32. Taking advantage of
the unique characteristics of LUBAC (i.e., loss of each LUBAC
subunit affects the amount of the complex to a different
extent), we generated HOIP conditional knockout mice to
establish three engineered mouse strains harboring Treg
expressing different levels of LUBAC (Sharpinfl/flFoxp3Cre >
Sharpinfl/flHoipfl/+Foxp3Cre>Hoipfl/flFoxp3Cre) (Supplementary
Fig. 5A, B). This enabled us to compare diseases provoked by
impairment of Treg expressing different levels of a single
component of the functional complex (Fig. 7a). Intriguingly,
these mice showed quite distinct inflammatory outcomes.
Comparative analyses of the three mouse strains revealed a
gradual reduction in the proportion and absolute number of
Treg in accordance with the reduced levels of LUBAC (Sup-
plementary Fig. 5C). Although expression of Treg functional
markers did not change, expression of Nrp1 and Helios by Treg
fell markedly upon Hoip ablation (Supplementary Fig. 5D, E).
In accordance with the reduction of LUBAC in Treg, the dis-
ease appeared to worsen and the number of inflamed organs
increased (Fig. 7b, Supplementary Fig. 5F, G). In addition to
the skin and lung, the pancreas in Sharpinfl/flHoipfl/+Foxp3Cre
mice, along with all tissues investigated in Hoipfl/flFoxp3Cre
mice, were affected. We also observed increased proportions of
activated (CD44hiCD62Llo, GITRhi, CD25hi, or CD69+) T cells
and an increase in Th2-dominant inflammation, which is
characterized by increased production of cytokines (IL-4, IL-5,
IL-10, and IL-13 from CD4+ T cells) and by secretion of IgG1
and IgE antibodies into the serum (Fig. 7c, d, Supplementary
Fig. 5H, I). In contrast to Sharpinfl/flFoxp3Cre skin lesions,
massive T cell infiltrates were observed in Hoipfl/flFoxp3Cre
lesions (Fig. 7e, f). Importantly, deletion of one allele of the
Hoip locus in Sharpinfl/flFoxp3Cre (Sharpinfl/flHoipfl/+Foxp3Cre)
mice rendered skin inflammation more severe and, intrigu-
ingly, the T cell-poor lesions in Sharpinfl/flFoxp3Cre mice were
converted to a T cell-dominant type in Sharpinfl/flHoipfl/+
Foxp3Cre mice, which can be regarded as an autoimmune dis-
ease (Fig. 7e–g). Moreover, it is noteworthy that epithelial cells
in Sharpinfl/flHoipfl/+Foxp3Cre mice underwent apoptotic and
necroptotic cell death, as observed in Sharpinfl/flFoxp3Cre mice
(Fig. 7h). Since the various types of inflammation observed
among the three strains were clearly T cell-dependent, the
pathologies of T cell-mediated autoimmune diseases are gen-
erally modulated by uncovered T cell-triggering innate
inflammatory responses.
Discussion
Elimination or suppression of Treg-mediated peripheral toler-
ance is sufficient to induce T cell-triggered immunological dis-
orders, which are categorized as autoimmune diseases33. Here,
we performed comprehensive analysis of mice bearing genetic
mutations of subunits of the trimetric LUBAC ubiquitin ligase
in Treg and demonstrated that impairment of Treg triggers
diverse pathological manifestations. Mice lacking HOIP, a cat-
alytic subunit of LUBAC, in Treg exhibited classical auto-
immune disease accompanied by massive lymphocyte
infiltration. However, mice lacking an accessory Sharpin subunit
specifically in Treg developed a quite distinct form of inflam-
mation, which is an apparently T cell-poor but innate immune
cell-dominant inflammatory response, although they still
exhibited some autoimmune traits such as activated peripherally
circulating T cells and autoantibody production. These results
demonstrating the pathological diversity of T cell-mediated
sterile inflammatory diseases appear to contradict the current
immunopathological definition, i.e., that self-reactive T cells
can be the main driver of autoimmunity but not autoin-
flammation. Our further analyses revealed that loss of an
additional Hoip locus in mice harboring Treg lacking Sharpin
(Sharpinfl/flHoipfl/+Foxp3Cre) resulted in more severe skin
inflammation in which both massive T cell infiltration and
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predominant keratinocyte cell death developed. Considering the
apparent innate inflammatory changes in Sharpinfl/flFoxp3Cre
mice (the strain showing the most mild impairment of Treg), the
results indicated that self-reactive T cells can readily provoke
innate inflammatory insults through T cell-mediated cytotoxi-
city rather than typical autoimmune responses.
TNFα, a well-known master proinflammatory cytokine, is
produced mainly by T cells, NK cells, monocytes, and activated
macrophages, and functions as a homotrimer complex of
membrane-bound or secreted forms to regulate immune-related
physiological processes or diseases. Here, we showed clear and


















































































































































































































































































Fig. 7 T cell-dependent autoinflammation is a pathogenesis common to several autoimmune diseases. a Schematic diagram showing genetic targeting of
LUBAC, leading to impairment of both TCR-mediated NF-κB signaling in Treg and Treg stability. b Tissues affected during chronic inflammation. Sk, Skin; Lu,
Lung; Li, Liver; St, Stomach; Ki, Kidney; Pa, Pancreas. c Percentage of CD44hiCD62Llo effector subsets or CD69+ recently activated subsets within the
CD4+Foxp3- or CD8+ T cell populations, respectively. Sharpinfl/flFoxp3Cr, n= 4; Sharpinfl/flHoipfl/+Foxp3Cre, n= 3; Hoipfl/flFoxp3Cre, n= 6 biologically
independent animals. d Percentage of cytokine-producing CD4+ T cells. CD4+ T cells isolated from secondary lymphoid tissues were stimulated with PMA
and ionomycin for 4 h before intracellular staining for each cytokine. Sharpinfl/flHoipfl/+Foxp3Cre, n= 3; the other strains, n= 5 biologically independent
animals. e Pathology underlying skin inflammation. Skin sections were subjected to Masson’s trichrome and immunofluorescence staining. Keratin14 (K14)
was used as a structural marker of the epidermis. Scale bars: 100 μm. The outlined areas are magnified in f. f Magnified photos from e and Fig. 4g.
g Representative appearance of skin inflammation. Inflammation in 5-week-old Sharpinfl/flHoipfl/+Foxp3Cre was more severe than that in Sharpinfl/flFoxp3Cre
mice. h Immunofluorescence staining of programmed cell death in skin from the indicated mice. Scale bars: 20 μm. Small circles indicate individual mice.
Small horizontal lines indicate the mean (±s.e.m.). *p < 0.05, **p < 0.01, ***p < 0.001. Kruskal-Wallis test with Bonferroni correction (α value= 0.05) was
used for c and d. Data are representative of at least three independent experiments (b, e, f, h) or pooled from three independent experiments (c, d). Also,
see Supplementary Fig. 5. Source data are provided in a Source Data file
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surface in response to TCR-mediated stimulation, along with its
direct association with death of epidermal cells in mice. Our co-
culture system revealed TNFα-induced T cell-mediated pro-
grammed cell death (Fig. 6d, e); therefore, upregulated TNFα
should be a primary inducer of cell death mediated by self-
reactive T cells. However, in our assays, MEFs and primary
keratinocytes from wild-type mice were not killed effectively in a
TNFα-dependent manner, even though they were co-cultured
with activated T cells. This implies that secondary signaling
mediated by inflammatory cytokines may be essential for
induction of TNFα-TNFRI-mediated cell death in a physiological
setting. For example, simultaneous activation of TNFRII expres-
sed by target cells might play a role since we detected upregulated
TNFRII expression on keratinocytes from Sharpinfl/flFoxp3Cre
mice. Secreted TNFα activates TNFRI preferentially, whereas
membrane-bound TNFα, expression of which is enforced in
activated T cells, strongly interacts with both TNFRI and TNFRII
to induce distinct signals. Unlike TNFRI, TNFRII cannot induce
cell death as it has no cytoplasmic death domain34. However,
upon binding to TNFα, TNFRII recruits TRAF2 and TRAF2-
associated protective factors, such as cIAP1 and cIAP2, which
may result in reduced recruitment of these signaling molecules to
TNFRI, leading to enhanced induction of TNFRI-mediated cell
death29,35,36. Also, other surface molecules, such as CD40L,
expressed on activated effector T cells via an as-yet-undetermined
mechanism may cooperate to facilitate TNFRI-mediated
necroptotic cell death28,30.
The TNFα-TNFRI axis induces two types of programmed cell
death under certain conditions: caspase-dependent apoptosis
and RIPK1-RIPK3-MLKL-dependent necroptosis. In this
context, we detected both types in the inflamed epidermis of
Sharpinfl/flFoxp3Cre mice. Necroptosis induces necrosis-like
morphological disruption and subsequently releases intracellular
factors, such as DAMPs, which can exacerbate inflammation.
Also, recent studies implicate necroptosis in the pathogenesis of
inflammatory bowel disease, systemic lupus erythematosus, and
multiple sclerosis37,38. TNFα-induced cell death in an in vitro co-
culture system was suppressed effectively by inhibiting necrop-
tosis (Fig. 6h), which led us to attempt deletion of RIPK3 from
Sharpinfl/flFoxp3Cre mice (Sharpinfl/flFoxp3CreRIPK3−/−) to assess
the contribution of necroptosis to the pathogenesis of innate
inflammation. Amelioration of dermatitis via loss of RIPK3
indicated a significant role for RIPK3-mediated necroptosis in
driving T cell-induced innate inflammation. However, apoptosis
may also contribute to some extent because loss of RIPK3 failed
to fully cure dermatitis in Sharpinfl/flFoxp3Cre mice (Fig. 6j, k).
These data may support previous reports showing that
deleting either RIPK3 or MLKL does not rescue cpdm mice
from autoinflammatory skin disease completely, whereas
RIPK3−/−Caspase-8+/− cpdm mice do not show overt symptoms
of dermatitis13,14. As shown in Sharpinfl/flK5CreFoxp3Cre mice,
overactivation of self-reactive T cells in autoinflammatory settings
induces apoptosis in most keratinocytes (Fig. 5f). Thus, apoptosis
induced by T cell-expressed TNFα in the skin might exhibit
inflammatory potential, although apoptosis is generally regarded
as a non-immunogenic form of cell death. It is unclear how
T cells would induce different types of cell death in vivo, or which
forms of cell death would contribute to different inflammatory
conditions. Therefore, further detailed studies are needed if we
are to gain better understanding of the mechanisms underlying T
cell-induced inflammation; such studies may lead to effective
therapeutic strategies for T cell-mediated (but apparently T cell-
poor) systemic inflammatory diseases.
In summary, we provide strong evidence that autoimmune-
prone T cells can initiate innate inflammation via TNFα-induced
cell death; as far as we are aware, this is a new concept with
respect to immune-mediated inflammatory mechanisms. Con-
sistent with our conclusions, TNFα plays crucial roles not only in
human autoinflammatory diseases but also in autoimmune dis-
eases such as rheumatoid arthritis, psoriasis, and Crohn’s disease.
In addition, based on our observation of apparent pathological
conversion of innate inflammatory skin in Sharpinfl/flK5Cre mice
into autoimmune skin in Sharpinfl/flK5CreFoxp3Cre mice, we
suggest that TNFα-mediated cytotoxicity via slightly activated
T cells may trigger innate-type inflammation, which is involved in
surprising diverse pathological outcomes depending on the
environment within the affected tissue. Thus, aberrant T cell
immune tolerance could induce autoimmunity and/or innate
inflammatory mechanisms that lead to complex T cell-mediated
immunopathophysiology. Our findings may explain the para-
doxical etiological outcomes and the propounded continuum
model for development of autoimmune and autoinflammatory
disorders39–41.
Methods
Mice. All animal use and care were performed according to protocols approved by
the Animal Research Committee, Graduate School of Medicine, Kyoto University,
and we complied with all the ethical regulations. All mice were housed at the
Institute of Laboratory Animals, Kyoto University, under specific pathogen-free
conditions, and all animal experiments were conducted in accordance with the
guidelines for animal experiments at Kyoto University and RIKEN Kobe Branch.
C57BL/6 (B6) mice were obtained from SLC, Japan. Cpdm mice were described
previously7. Rag2−/− mice were obtained from the Central Institute of Experi-
mental Animals, Japan. TNFα−/− (Stock number: 003008) and B6 (CD45.1) (Stock
number: 002014) mice were obtained from the Jackson Laboratory. Lck-Cre
(Model number: 4197) transgenic mice were obtained from Taconic. β5t-iCre
knock-in mice and Foxp3-YFP/iCre knock-in mice were kindly provided by You-
suke Takahama (University of Tokushima, Japan) and Alexander Y. Rudensky
(Memorial Sloan Kettering Cancer Center, USA), respectively42,43. Ripk3−/− mice
were kindly provided by Vishva Dixit (Genentech, USA)44. K5-Cre mice were
obtained from CARD-Kumamoto University, Japan45. Sharpin conditional KO,
HOIP conditional KO, and Sharpin conditional transgenic mice were generated in-
house, and are available from RIKEN BRC, Japan.
Generation of conditional Sharpin-KO mice. A targeting vector for floxed
Sharpin mutant mice was constructed by inserting loxP sequences bracketing exons
3–9 of the Sharpin gene, which encodes the ubiquitin-like (UBL) domain and a
NZF domain of the Sharpin protein and is deleted after expression of Cre
recombinase. A neomycin resistance gene flanked by FRT sites was inserted into
intron 2. Bruce 4 C57BL/6 embryonic stem (ES) cells were transfected with the
targeting vector and screened as neomycin-resistant colonies. Appropriate homo-
logous recombination was confirmed by Southern blot analysis. The targeted ES
cells were injected into recipient blastocysts to generate germline-transmitting
chimeras. Mice carrying the mutated Sharpin locus were crossed with Flp Deleter
mice to delete the neomycin cassette and then backcrossed onto the C57BL/6N
strain for at least five generations before analysis. The following PCR primers were
used to genotype the conditional Sharpin-KO mice: Forward (Fw-Intron2),
GTGACAAGGTCTCAATGTGAAT; Reverse (Rv-Intron2), CTGTAATCCCAGT
GTTCATATG; and Reverse (Rv-CYC1), TCCATGGCCTTCTCAGGCC. Size of
floxed allele: 500 bp; size of wild-type allele: 370 bp.
Generation of conditional HOIP-KO mice. A targeting vector for floxed Hoip
mutant mice was constructed by inserting loxP sequences bracketing exons 7–11 of
the Hoip gene, which encodes the zinc finger domains and ubiquitin-associated
(UBA) domain of the HOIP protein and is deleted after expression of Cre
recombinase. A neomycin resistance gene flanked by FRT sites was then inserted
into intron 6. JM8 C57BL/6 N ES cells were then transfected with the targeting
vector. The following steps were the same as those used to generate conditional
Sharpin-KO mice. The PCR primers used to genotype the conditional HOIP-KO
mice were as follows: Forward (fl–f4), ACACTAAGCAAGTAGCAGCCAC; and
Reverse (fl–r5), GCTCTGGCCTTTCTGATTGCTG. Size of floxed allele: 370 bp;
size of wild-type allele: 220 bp.
Generation of conditional Sharpin transgenic mice. A targeting vector for
conditional Sharpin transgenic mice was constructed by insertion of the Sharpin
sequence fused to an N-terminal FLAG-His tag, followed by the FRT-flanking
IRES-EGFP cassette plus the polyA sequence, into the Rosa26 locus. The neomycin
resistance gene and Stop sequences were flanked by loxP sequences and placed
upstream of the sequence encoding Sharpin such that Sharpin was expressed under
control of the Rosa promoter after Cre recombinase-mediated excision. TT2
(C57BL/6N × CBA) ES cells were transfected with the targeting vector. This strain
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was used without crossing with Flp Deleter mice to detect targeted cells according
to expression of the EGFP reporter. The PCR primers used to genotype the con-
ditional Sharpin transgenic mice (accession no. CDB1201K: http://www2.clst.riken.
jp/arg/mutant%20mice%20list.html) were as follows: Forward (wild-type allele),
CCAGATGACTACCTATCCTC; Reverse (wild-type allele), GAGCTGCAGTGG
AGTAGGCG; Forward (mutant allele) (f2), CTTGCCCTTCCTGCACTTTCATC;
Reverse (mutant allele) (r4), GCAATATGGTGGAAAATAAC. Size of wild-type
allele: 350 bp; size of floxed mutant allele: 300 bp.
Cells and generation of CRISPR/Cas9-mediated KO cell lines. HOIP-KO Jurkat
cells and Hoil-1l−/− and Sharpin−/− MEFs were generated as described
previously46,47. Gene-targeting KO B3Z, kindly provided from Takayuki Kanaseki
(Sapporo Medical University, Japan), Jurkat, and Sharpin−/− MEF cells were
generated using the CRISPR/CAS9 system. The CRISPR design tool (crispr.mit.
edu) was used to select target guide sequences. The synthesized sgRNA oligos (see
below) were phosphorylated, annealed, and inserted into the pair of BbsI sites in
pSpCas9(BB)-2A-GFP (PX458, Addgene). The plasmids were transfected into cells
by electroporation. After 24 h, GFP-expressing cells were purified using a FAC-
SAria III cell sorter (BD Biosciences), according to the manufacturer’s protocol,
and single cell clones were obtained by limiting dilution. Disappearance of targeted
proteins was determined by western blot analysis or flow cytometry analysis. The
CRISPR sgRNA sequences (gene name, sgRNA number, and sequence) were as
follows: human Sharpin sgRNA#1, GCGGTGGGCAGTCCTAGTCCG; human
Sharpin sgRNA#2, GCCACGGTGGCACCTCGGACT; mouse Sharpin sgRNA#1,
GTGGCAGTGCACGCGGCGGTC; mouse Sharpin sgRNA#2, GACTGCCGCAC
CGCCGGCGGG; mouse Hoip sgRNA#1, GTGGTCCGCTGCAACGCTCAT;
mouse Hoip sgRNA#2, CACCGCAGCTGGACGCCGGACGCT; mouse β2m
sgRNA, GTCACGCCACCCACCGGAGAA; mouse Tap1 sgRNA#1, GTCCTAGG
ACTAGGGGTCCGC; mouse Tap1 sgRNA#2, GCCTAGGACTAGGGGTCCGCG;
mouse Tnfrsf1a sgRNA#1, GTGTCACGGTGCCGTTGAAGC; mouse Tnfrsf1a
sgRNA#2, GCACTCAGGTAGCGTTGGAAC.
In vitro T cell-inducible cell death assay. Primary T cells were isolated from
secondary lymphoid tissues using anti-CD4, CD8α, or Thy1.2 MACS microbeads
(Miltenyi Biotec). The T cells (1–2 × 105) were co-cultured for 10 h with MEFs
(target cells; 5 × 104) in a 96-well flat-bottom plate (200 μl/well). Floating T cells
were removed by washing three times with medium. Survival of target cells was
measured in a MTT assay (Dojindo, Japan), according to the manufacturer’s
protocol. For some experiments, z-VAD-fmk (20 μM, MBL) and/or Necrostatin-1
(50 μM, Sigma), a titrated neutralizing antibody against TNFα (XT3.11, Bio X cell),
a rat IgG1 isotype control (HRPN, Bio X cell), or Fc-fused TNFRII (Etanercept,
Pfizer) was added to the wells. For the siRNA knockdown experiment, target cells
were plated in a 6-well plate (1 × 105/well). One day later, cells were treated with
each siRNA (12.5 nM) diluted in Opti-MEM (Gibco). After 2 days, cells were
harvested and used as target cells. The target genes and siRNA sequences were as
follows: mouse Fadd siRNA#1, GGCACAUGUGCUGACUGCATT; mouse Fadd
siRNA#2, GCAACGAUCUGAUGGAGCUTT; mouse Ripk3 siRNA, CUCAAGUU
CGGCCAAGUAUTT; mouse Casp8 siRNA#1, GACAUAACCCAACUCCG
AATT; and mouse Casp8 siRNA#2, GUGAAUGGAACCUGGUAUATT.
Staining of dead cells. After exposure to T cell-inducible cell death assay
immobilized in a collagen-coated plate, floating cells (including T cells) were
removed by washing with PBS. The cells were then stained for 30 min at room
temperature in the dark with TO-PRO3 (1 μM, ThermoFisher Scientific) and
Hoechst33342 (5 μg/ml, Molecular Probes). After washing, photomicrographs of
dead cells were acquired under a Keyence Fluorescence Microscope (BZ-9000)
using CFI Plan Apo ×40 0.95/0.14 mm objective lenses (Nikon). The observed
signals were processed using the BZ-II image analysis application (Keyence).
Measurement of cell viability using iCelligence. The real-time cell analyzer
iCelligence system (ACEA Biosciences) was used as described47. Cell death inhi-
bitors z-VAD-fmk (100 μM, MBL) and/or Necrostatin-1 (50 μM, Sigma) were
added 1 h before administration of purified T cells.
In vitro T cell stimulation. Primary T cells were isolated from splenocytes
using anti-Thy1.2 MACS microbeads (Miltenyi Biotec). Then, 1 × 106 T cells
were stimulated with a soluble anti-CD3ε antibody (1 μg/ml) or with a
combination of an anti-CD3ε antibody (1 μl/ml) and a soluble anti-CD28
antibody (1 μg/ml).
T cell hybridoma stimulation assay. CD8+ B3Z T cell hybridomas were stimu-
lated by pOVA (SIINFEKL) presented on H2Kb murine MHC class I molecules, as
previously reported48,49. The pOVA was purchased from MBL. Kb-expressing L
cells, kindly provided from Nilabh Shastri (University of California, USA), were
used as APCs. The T cell hybridoma (1 × 105/well) was incubated for 24 h with the
APCs (1 × 105/well) in the presence of titrated amounts of exogenous peptide. The
culture supernatants were then added to IL-2-dependent HT-2 cells, kindly
provided from Eric Huseby (University of Massachusetts Medical School, USA),
(4 × 103/well) and incubated for 24 h. Cytokine production by T cells was assessed
by measuring proliferation of HT-2 cells in a MTT assay (Dojindo). All experi-
ments were repeated three times, each with similar results.
Antibodies used for flow cytometry analysis. The following mouse antibodies
were used: anti-CD25 (PC61, 102006), anti-IFNγ (XMG1.2, 505806), anti-CD103
(2E7, 121420), anti-GITR (YGITR765, 120205), anti-CD44 (IM7, 103008), anti-IL-
4 (11B11, 504104), anti-CD4 (GK1.5, 100434), anti-CD25 (PC61, 102029), anti-IL-
5 (TRFK5, 504303), anti-CD62L (MEL-14, 104412), anti-CD69 (H1.2F3, 104513),
anti-Gr1 (RB6-8C5, 108411), anti-CD103 (2E7, 121403), anti-IL-17A (TC11-
18H10.1, 506916), anti-GITR (DTA-1, 126311), anti-CD304 (Nrp1) (3E12,
145209), anti-CD3ε (145-2C11, 100334), anti-CD19 (6D5, 115519), anti-CD152
(CTLA4) (UC10-4B9, 106313), anti-B220 (RA3-6B2, 103224), streptavidin-PerCP
(405213), anti-KLRG1 (2F1/KLRG1, 138409), anti-CD11b (M1/70, 101215), anti-
Helios (22F6, 137216), anti-CD154 (CD40L) (MR1, 106505), anti-CD120a
(TNFRI) (55R-286, 113003), anti-CD120b (TNFRII) (TR75-89, 113405), anti-
CD262 (DR5, TRAIL-R2) (MD5-1, 119905), and anti-CD3ε (145-2C11, 100333)
(all from BioLegend); anti-CD3ε (145-2C11, 553062), anti-CD11b (M1/70,
553310), anti-B220 (RA3-6B2, 11-0452-82), anti-CD5 (53-7.3, 553022), anti-CD25
(PC61, 552880), anti-CD8α (53-6.7, 552877), anti-CD19 (1D3, 562701),
streptavidin-APC-Cy7 (554063), anti-CD69 (H1.2F3, 553237), anti-CD95 (Fas)
(Jo2, 554258), and anti-SiglecF (E50-2440, 552126) (all from BD Biosciences); anti-
TCRβ (H57-597, 11-5961-82), anti-CD25 (PC61.5, 12-0251-82), anti-Ki-67
(SolA15, 12-5698-80), anti-IFNγ (XMG1.2, 12-7311-81), anti-CD4 (RM4-5, 17-
0042-82), anti-B220 (RA3-6B2, 17-0452-83), anti-IL-13 (eBio13A, 50-7133-80),
anti-γδTCR (eBioGL3, 13-5711-81), streptavidin-APC (17-4317-82), anti-NK1.1
(PK136, 17-5941-81), anti-CD45RB (C363.16A, 12-0455-82), anti-Foxp3 (FJK-16s,
11-5773-82), anti-CD19 (eBio1D3, 11-0193-82), anti-TCRβ (H57-597, 12-5961-
82), anti-IL-2 (JES6-5H4, 12-7021-81), streptavidin-PE (12-4317-87), anti-CD62L
(MEL-14, 13-0621-82), anti-NK1.1 (PK136, 13-5941-82), anti-TNFα (MP6-XT22,
17-7321-81), anti-IL-10 (JES5-16E3, 17-7101-81), and anti-IFNγ (XMG1.2, 17-
7311-81) (all from eBioscience); anti-CD127 (A7R34, 50-1271-U025) (TONBO
Biosciences); and anti-p-ERK (D13.14.4E, 4344), anti-p-p65 (93H1, 4886), and
anti-IκBα (L35A5, 7523) (all from Cell Signaling Technology). All antibodies used
for flow cytometory analysis were diluted at 1:200 before staining.
Western blot analysis. Jurkat cells, thymocytes, MACS-purified T cells, or sorted
(TCRβ+CD4+Foxp3+CD25+) Treg were lysed on ice in 1% Nonidet P-40/PBS/
protease inhibitor cocktail (Roche) and then clarified by centrifugation at 20,000×g
for 5 min at 4 °C. The purified lysate was used for SDS-PAGE and immunoblot
analysis as described previously7. Chemiluminescent signals were detected using an
ImageQuant LAS 4000 Image reader (Fujifilm). Antibodies against LUBAC com-
ponents were described previously6,7. Anti-α-tubulin (DM1A, CLT9002, 1:5000
dilution) was purchased from Cedarlane Laboratories. Anti-β-actin (AC-74, A5316,
1:5000 dilution) was purchased from Sigma.
Luciferase assay for measurement of NF-κB signaling. The luciferase reporter
plasmids pGL-NF-κB-Luc (10 μg) and pGL-TK-Luc (10 μg) (Promega) were
electroporated (250 V, 950 μF) into Jurkat cells (5 × 106). After 48 h, cells were
collected and stimulated with murine recombinant TNFα (20 ng/ml, R&D Systems)
or anti-CD3ε/CD28 antibodies (1 μg/ml, BioLegend) for the indicated times. Next,
the cells were lysed and ligand-dependent NF-κB activity was measured (in terms
of luciferase activity) using the Dual-Luciferase Reporter or Bright-Glo luciferase
assay system (Promega), according to the manufacturer’s protocol. Luminescence
was detected in a Lumat luminometer (Berthold).
Lentiviral transduction of Jurkat cells. Human wild-type or mutant Hoip cDNA
was inserted into pCSII-EF-MCS-IRES2-Venus. Each plasmid was then transfected
into 293 T cells along with pCMV-VSV-G-RSV-Rev and pMDLg/pRRE plasmids.
After 12 h, the culture medium was replaced with fresh DMEM containing 10 μM
forskolin and left for 72 h. Lentivirus in the culture supernatant was concentrated
using a Lenti-X concentrator (Takara), and the lentiviral titer was determined by
measuring Venus expression. Jurkat cells were infected with lentivirus (multiplicity
of infection= 10) in the presence of polybrene (10 μg/ml). Infected Venus+ Jurkat
cells were enriched using a FACSAria III cell sorter (BD Biosciences), according to
the manufacturer’s protocol.
Histologic analysis. Mice were deeply anesthetized, and organs were removed and
dissected (except for the lung). Each tissue was fixed immediately in 10% formalin
solution buffered with PBS. Lung tissue was prefixed by perfusion with fixation
solution via the trachea using a SURFLO ETFE I.V. Catheter (24G × 3/4″; TER-
UMO) and then dissected and immersed in fixation solution for a further 48 h. The
fixed organs were embedded in paraffin wax and sectioned. All sections were
stained with H/E. Skin sections were stained with Masson’s trichrome stain to
visualize fibrosis in inflamed areas. Photomicrographs were acquired under an
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Olympus BX51 upright microscope using UPlan Apo ×10/0.40, UPlan Apo ×20/
0.70, and UPlan Fl ×40/0.75 objective lenses (Olympus).
Immunofluorescence analysis of skin sections. Formalin-fixed paraffin-
embedded sections were deparaffinized, immersed in citrate buffer (10 mM citric
acid, pH 6.0), and then boiled for 20–40 min in a microwave processor (MI-77;
Azumayaika, Japan) for antigen retrieval. After sections were blocked for 30 min at
room temperature with an anti-CD16/32 antibody (2 μg/ml) in 5% goat serum-
containing blocking buffer (2% BSA, 0.1% Triton X-100, and 0.02% sodium azide
in PBS), they were stained overnight at 4 °C with the following antibodies in
blocking buffer: anti-CD3ε (HH3E, DIA-303; Dianova), anti-keratin14 (PRB-155P,
Covance), anti-F4/80 (Cl:A3-1, MCA497GA; BIO-RAD), anti-myeloperoxidase
(MPO) (RB-373-A1, ThermoFisher Scientific), anti-cleaved caspase-3 (Asp175,
9661; Cell Signaling Technology), and anti-phospho (S345)-MLKL (EPR9515(2),
ab196436; Abcam). The stained sections were then incubated for 1 h at room
temperature with a mixture of the following fluorescent dye-conjugated antibodies
in blocking buffer: goat anti-rat IgG-AlexaFluor 647 (A-21247) and goat anti-rabbit
IgG-AlexaFluor 488 (A-11034) (ThermoFisher Scientific). For preservation, labeled
sections were mounted in ProLong Gold or ProLong Diamond Antifade Mountant
(ThermoFisher Scientific) containing DAPI. Photomicrographs were acquired
under a Keyence Fluorescence Microscope BZ-9000 using CFI Plan Apo ×40 0.95/
0.14 mm objective lenses (Nikon) or an Olympus FLUOVIEW FV1000 confocal
laser scanning microscope using a Plan Apo N ×60 /1.42 objective lens (Olympus).
The observed signals were processed using the BZ-II image analysis application
(Keyence).
TUNEL staining. Formalin-fixed, paraffin-embedded skin sections were used for
TUNEL staining. After deparaffinization, sections were treated for 1 h at room
temperature with Proteinase K (10 μg/ml in 10 mM Tris-HCl, pH 7.4). The
TUNEL reaction was performed using the In Situ Cell Death Detection Kit,
Fluorescein (Roche). For preservation, labeled sections were mounted in ProLong
Gold Antifade Mountant (ThermoFisher Scientific) containing DAPI. Fluorescence
images of apoptotic cells were acquired under a Keyence Fluorescence Microscope
BZ-9000 using CFI Plan Apo ×40 0.95/0.14 mm objective lenses (Nikon). The
observed signals were processed using the BZ-II image analysis application
(Keyence).
Cell isolation from tissues and staining for flow cytometry. Thymocytes from
4- to 5-week-old mice, and splenocytes and lymph node cells from 4- to 10-week-
old mice, were stained with a mixture of antibodies (see above). Cells infiltrating
the liver of 8- to 10-week-old mice were isolated by mechanical dissociation using a
100 μm cell strainer (Falcon), followed by purification on a 33% Percoll solution
(Sigma). Skin-resident cells were isolated separately from the dermis or epidermis.
After shaving, the skin was immersed in 0.5 g/ml Dispase II (Wako) diluted in PBS
and left at 4 °C overnight. The epidermal layer was then peeled from the dermis.
Epidermal tissues were treated at 37 °C for 10 min with 0.05% DNase I (Roche)
containing trypsin solution. Dermal tissues were incubated with 0.13 units/ml
Liberase TM (Roche) and 100 μg/ml DNase I (Roche) diluted in plain RPMI1640
and then rotated at 37 °C for 40 min. The cell suspension obtained from each tissue
was then filtered through 100 μm nylon filter mesh. For intracellular staining of
transcription factors, including Foxp3, surface-labeled cells were fixed, permeabi-
lized, and stained using the Foxp3/Transcription Factor Staining Buffer Set
(eBioscience), according to the manufacturer’s protocol. To examine the ability of
T cells to produce cytokines, cells isolated from each organ were stimulated for 4 h
at 37 °C with 50 ng/ml PMA and 750 ng/ml ionomycin in the presence of the
protein transport inhibitors GolgiStop/GolgiPlug (1:1000; BD Biosciences). After
surface staining, stimulated cells were fixed, permeabilized, and stained using the
Fixation/Permeabilization Solution Kit (BD Biosciences), according to the manu-
facturer’s protocol. For p-STAT5 staining, isolated cells were fixed for 1 h at room
temperature with 4% formalin containing PBS and then treated with cold methanol
for 1 h on ice before staining. For p-p65, IκBα, and p-ERK staining, stimulated cells
were fixed for 10 min at 37 °C with Lyse/Fix buffer (BD Biosciences) and then
washed with Perm/Wash buffer (eBioscience) before staining. To detect intracel-
lular caspase activity in epidermal cells by flow cytometry, isolated cells were
incubated at 37 °C for 30 min with PhiPhiLux-G1D2 (OncoImmunin, Inc.). All
antibodies were used at 1:200, except for the anti-CD3ε antibody (used at 1:100).
Flow cytometry analysis was performed using a FACSCanto II flow cytometer (BD
Biosciences), according to the manufacturer’s protocol. Data were analyzed using
FlowJo software (Tomy Digital Biology).
T cell-induced colitis and in vivo Treg suppression assay. Splenocytes and LN
cells from 4–5-week-old B6 (CD45.1+) mice were depleted with anti-CD19 and
anti-CD8α MACS microbeads (Miltenyi) to enrich CD4+ T cells. Next, pre-
enriched cells were stained with a mixture of antibodies, including anti-CD25,
anti-CD4, anti-CD3ε, and anti-CD45RB, followed by staining of dead cells with
LIVE/DEAD Fixable Dead Cell Stains (Molecular Probes). Labeled cells were
used for T cell sorting with a FACSAria III cell sorter (BD Biosciences) to purify
CD45RBhiCD25-CD4+ naïve T cells. The sorted population was >98% pure.
Foxp3/YFP+CD25+CD4+CD3ε+ (CD45.2+) Treg from control or Sharpinfl/
flFoxp3Cre mice were prepared in a similar manner. Briefly, 2 × 105 purified
naïve T cells, either alone or in combination with 1 × 105 purified control or
Sharpin-KO Treg, were suspended in HBSS and injected intravenously
into Rag2−/− mice (five to six Rag2−/− mice per group). Recipient mice
were monitored for colitis progression by weighing two or three times per
week. At 4 weeks post-transfer, recipient mice were sacrificed for further
experiments.
Quantitative PCR analysis of skin. After removing hair with an electric shaver,
part of the dorsal skin was dissected. Pre-cleaned RNAs were extracted using
Sepasol-RNA I Super G (Nacalai Tesque, Japan), according to the manufacturer’s
protocol, and then subjected to column-based purification using an RNeasy Mini
Kit (Qiagen). Skin cDNA was obtained by reverse transcription of RNA using a
High-Capacity RNA-to-cDNA Kit (Applied Biosystems), followed by qPCR ana-
lysis using SYBR Green PCR Master Mix (Applied Biosystems) and a ViiA7 Real-
time PCR system (Applied Biosystems). The qPCR amplification conditions were
as follows: 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s and 60 °C for 1
min. Expression of each gene was normalized against that of hypoxanthine-guanine
phosphoribosyl transferase (HPRT). The following primers were used: mouse
HPRT, Forward, GATTAGCGATGATGAACCAGGTT, and Reverse,
CCTCCCATCTCCTTCATGACA; mouse IL-6, Forward, TACCACTTCACAAG
TCGGAGGC, and Reverse, CTGCAAGTGCATCATCGTTGTTC; mouse TNFα,
Forward, GGTGCCTATGTCTCAGCCTCTT, and Reverse, GCCATAGAAC
TGATGAGAGGGAG; mouse IL-1β, Forward, TGGACCTTCCAGGATGAGG
ACA, and Reverse, GTTCATCTCGGAGCCTGTAGTG; and mouse IL-4, Forward,
ATCATCGGCATTTTGAACGAGGTC, and Reverse, ACCTTGGAAGCCCTA
CAGACGA.
Scoring for dermatitis. The disease scoring system was described previously50. In
brief, the skin was divided into four regions (head; neck and/or back; front limbs
and/or ventral area; and hind limbs and/or rump area). Each inflamed region
scores 1 point, except for the head, which scores 2 points. Additionally, the severity
of each affected area was graded as follows: 0= no disease; 1= hair loss and mild
scaling; 2= extensive scaling and erosion; 3= ulceration. The final score for each
individual mouse was the sum of the scores for each affected region plus the
severity grade (maximum score, 17 points). All mice were scored two or three times
per week during the experiment.
B cell or myeloid cell depletion. To deplete B cells or myeloid cells, 4-week-old
mice received an intraperitoneal injection of both anti-CD19 (1D3) and anti-B220
(RA3.3A1/6.1), or anti-Gr1 (RB6-8C5), or Isotype control (LTF2) antibodies; these
injections were given five times per week.
In vivo TNFα neutralization. A total of 200 μg of an anti-TNFα Ab (clone XT3.11)
or isotype control IgG (clone HRPN) was intraperitoneally administrated to 3-week-
old mice. The mice received one injection every 3 days, and that was repeated eight
times.
Microarray analysis. Total RNA was extracted from FACS-sorted Treg using an
RNeasy Mini Kit (Qiagen), according to the manufacturer’s instructions. The
purity of the RNA was checked using a NanoDrop 2000 spectrophotometer
(ThermoFisher Scientific) and a 2100 Bioanalyzer (Agilent Technologies). Bioti-
nylated cRNA was synthesized from 250 ng of total RNA using the GeneChip 3′
IVT PLUS Reagent Kit (Affymetrix), according to the manufacturer’s instructions.
The yield of biotinylated cRNA was checked using the NanoDrop 2000 spectro-
photometer. Following fragmentation, 15 μg of cRNA was hybridized to a Gene-
Chip Mouse Genome 430 2.0 Array (Affymetrix) for 16 h at 45 °C. Arrays were
washed and stained in a GeneChip Fluidics Station 450 (Affymetrix). Arrays were
scanned using GeneChip Scanner 3000 7G. Single Array Analysis was calculated
using Microarray Suite version 5.0 (MAS5.0), with the Affymetrix default setting
and global scaling as the normalization method. The trimmed mean target intensity
of each array was arbitrarily set to 500.
Statistical analysis. Statistical analysis was performed using Prism 5.0c (Graph-
Pad software). Statistical significance was determined using a two-tailed
Mann–Whitney U-test, a paired t-test, or the Kruskal-Wallis test, followed by
pairwise comparisons with Bonferroni-corrected Dunn’s test. A p-value of 0.05 was
deemed significant.
Reporting summary. Further information on research design is available in the
Nature Research Reporting Summary linked to this article.
Data availability
The Gene Expression Omnibus accession number for the transcriptional data reported in
this study is GSE108793. The authors declare that all other data of this study are available
within the paper or upon reasonable request. The source data are provided in a Source
Data file.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11858-7
14 NATURE COMMUNICATIONS |         (2019) 10:3878 | https://doi.org/10.1038/s41467-019-11858-7 | www.nature.com/naturecommunications
Received: 29 October 2018 Accepted: 8 August 2019
References
1. Boisson, B. et al. Human HOIP and LUBAC deficiency underlies
autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia.
J. Exp. Med. 212, 939–951 (2015).
2. Boisson, B. et al. Immunodeficiency, autoinflammation and amylopectinosis
in humans with inherited HOIL-1 and LUBAC deficiency. Nat. Immunol. 13,
1178–1186 (2012).
3. Sasaki, Y. et al. Defective immune responses in mice lacking LUBAC-mediated
linear ubiquitination in B cells. EMBO J. 32, 2463–2476 (2013).
4. Gerlach, B. et al. Linear ubiquitination prevents inflammation and regulates
immune signalling. Nature 471, 591–596 (2011).
5. Ikeda, F. et al. SHARPIN forms a linear ubiquitin ligase complex regulating
NF-kappaB activity and apoptosis. Nature 471, 637–641 (2011).
6. Kirisako, T. et al. A ubiquitin ligase complex assembles linear polyubiquitin
chains. EMBO J. 25, 4877–4887 (2006).
7. Tokunaga, F. et al. SHARPIN is a component of the NF-kappaB-activating
linear ubiquitin chain assembly complex. Nature 471, 633–636 (2011).
8. Tokunaga, F. et al. Involvement of linear polyubiquitylation of NEMO in NF-
kappaB activation. Nat. Cell Biol. 11, 123–132 (2009).
9. Haas, T. L. et al. Recruitment of the linear ubiquitin chain assembly complex
stabilizes the TNF-R1 signaling complex and is required for TNF-mediated
gene induction. Mol. Cell 36, 831–844 (2009).
10. Peltzer, N. et al. HOIP deficiency causes embryonic lethality by aberrant
TNFR1-mediated endothelial cell death. Cell Rep. 9, 153–165 (2014).
11. Fujita, H. et al. Cooperative domain formation by homologous motifs in
HOIL-1L and SHARPIN plays a crucial role in LUBAC stabilization. Cell Rep.
23, 1192–1204 (2018).
12. Berger, S. B. et al. Cutting edge: RIP1 kinase activity is dispensable for normal
development but is a key regulator of inflammation in SHARPIN-deficient
mice. J. Immunol. 192, 5476–5480 (2014).
13. Kumari, S. et al. Sharpin prevents skin inflammation by inhibiting TNFR1-
induced keratinocyte apoptosis. eLife https://doi.org/10.7554/eLife.03422 (2014).
14. Rickard, J. A. et al. TNFR1-dependent cell death drives inflammation in
Sharpin-deficient mice. eLife https://doi.org/10.7554/eLife.03464 (2014).
15. de Jesus, A. A., Canna, S. W., Liu, Y. & Goldbach-Mansky, R. Molecular
mechanisms in genetically defined autoinflammatory diseases: disorders of
amplified danger signaling. Annu. Rev. Immunol. 33, 823–874 (2015).
16. Masters, S. L., Simon, A., Aksentijevich, I. & Kastner, D. L. Horror
autoinflammaticus: the molecular pathophysiology of autoinflammatory
disease (*). Annu. Rev. Immunol. 27, 621–668 (2009).
17. HogenEsch, H. et al. A spontaneous mutation characterized by chronic
proliferative dermatitis in C57BL mice. Am. J. Pathol. 143, 972–982 (1993).
18. Potter, C. S. et al. Chronic proliferative dermatitis in Sharpin null mice:
development of an autoinflammatory disease in the absence of B and T
lymphocytes and IL4/IL13 signaling. PLoS ONE 9, e85666 (2014).
19. Gijbels, M. J., HogenEsch, H., Bruijnzeel, P. L., Elliott, G. R. & Zurcher, C.
Maintenance of donor phenotype after full-thickness skin transplantation
from mice with chronic proliferative dermatitis (cpdm/cpdm) to C57BL/Ka
and nude mice and vice versa. J. Invest. Dermatol. 105, 769–773 (1995).
20. Park, Y. et al. SHARPIN controls regulatory T cells by negatively modulating
the T cell antigen receptor complex. Nat. Immunol. 17, 286–296 (2016).
21. Redecke, V., Chaturvedi, V., Kuriakose, J. & Hacker, H. SHARPIN controls
the development of regulatory T cells. Immunology 148, 216–226 (2016).
22. Dubois, S. M. et al. A catalytic-independent role for the LUBAC in NF-kappaB
activation upon antigen receptor engagement and in lymphoma cells. Blood
123, 2199–2203 (2014).
23. Weinlich, R., Oberst, A., Beere, H. M. & Green, D. R. Necroptosis in development,
inflammation and disease. Nat. Rev. Mol. Cell Biol. 18, 127–136 (2017).
24. Pasparakis, M. & Vandenabeele, P. Necroptosis and its role in inflammation.
Nature 517, 311–320 (2015).
25. Vercammen, D. et al. Inhibition of caspases increases the sensitivity of L929
cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187,
1477–1485 (1998).
26. Park, C. O. & Kupper, T. S. The emerging role of resident memory T cells in
protective immunity and inflammatory disease. Nat. Med. 21, 688–697 (2015).
27. Turner, D. L., Gordon, C. L. & Farber, D. L. Tissue-resident T cells, in situ
immunity and transplantation. Immunol. Rev. 258, 150–166 (2014).
28. Grell, M. et al. Induction of cell death by tumour necrosis factor (TNF)
receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous
membrane-anchored TNF. EMBO J. 18, 3034–3043 (1999).
29. Li, X., Yang, Y. & Ashwell, J. D. TNF-RII and c-IAP1 mediate ubiquitination
and degradation of TRAF2. Nature 416, 345–347 (2002).
30. Qiu, X., Klausen, C., Cheng, J. C. & Leung, P. C. CD40 ligand induces RIP1-
dependent, necroptosis-like cell death in low-grade serous but not serous
borderline ovarian tumor cells. Cell Death Dis. 6, e1864 (2015).
31. Siegmund, D., Kums, J., Ehrenschwender, M. & Wajant, H. Activation of
TNFR2 sensitizes macrophages for TNFR1-mediated necroptosis. Cell Death
Dis. 7, e2375 (2016).
32. Teh, C. E. et al. Linear ubiquitin chain assembly complex coordinates late
thymic T-cell differentiation and regulatory T-cell homeostasis. Nat.
Commun. 7, 13353 (2016).
33. Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and
immune tolerance. Cell 133, 775–787 (2008).
34. Rothe, M., Wong, S. C., Henzel, W. J. & Goeddel, D. V. A novel family of
putative signal transducers associated with the cytoplasmic domain of the 75
kDa tumor necrosis factor receptor. Cell 78, 681–692 (1994).
35. Mehta, A. K., Gracias, D. T. & Croft, M. TNF activity and T cells. Cytokine
101, 14–18 (2018).
36. Wajant, H., Pfizenmaier, K. & Scheurich, P. Tumor necrosis factor signaling.
Cell Death Differ. 10, 45–65 (2003).
37. Fenton, K. The effect of cell death in the initiation of lupus nephritis. Clin.
Exp. Immunol. 179, 11–16 (2015).
38. Ofengeim, D. et al. Activation of necroptosis in multiple sclerosis. Cell Rep. 10,
1836–1849 (2015).
39. Grateau, G. et al. How should we approach classification of autoinflammatory
diseases? Nat. Rev. Rheumatol. 9, 624–629 (2013).
40. Hedrich, C. M. Shaping the spectrum—from autoinflammation to
autoimmunity. Clin. Immunol. 165, 21–28 (2016).
41. van Kempen, T. S., Wenink, M. H., Leijten, E. F., Radstake, T. R. & Boes, M.
Perception of self: distinguishing autoimmunity from autoinflammation. Nat.
Rev. Rheumatol. 11, 483–492 (2015).
42. Ohigashi, I. et al. Aire-expressing thymic medullary epithelial cells originate
from beta5t-expressing progenitor cells. Proc. Natl Acad. Sci. USA 110,
9885–9890 (2013).
43. Rubtsov, Y. P. et al. Regulatory T cell-derived interleukin-10 limits
inflammation at environmental interfaces. Immunity 28, 546–558 (2008).
44. Newton, K., Sun, X. & Dixit, V. M. Kinase RIP3 is dispensable for normal NF-
kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor
receptor 1, and Toll-like receptors 2 and 4. Mol. Cell Biol. 24, 1464–1469
(2004).
45. Tarutani, M. et al. Tissue-specific knockout of the mouse Pig-a gene reveals
important roles for GPI-anchored proteins in skin development. Proc. Natl
Acad. Sci. USA 94, 7400–7405 (1997).
46. Sakamoto, H. et al. Gliotoxin suppresses NF-kappaB activation by selectively
inhibiting linear ubiquitin chain assembly complex (LUBAC). ACS Chem.
Biol. 10, 675–681 (2015).
47. Shimizu, S. et al. Differential involvement of the Npl4 zinc finger domains of
SHARPIN and HOIL-1L in linear ubiquitin chain assembly complex-
mediated cell death protection. Mol. Cell Biol. 36, 1569–1583 (2016).
48. Huseby, E. S. et al. How the T cell repertoire becomes peptide and MHC
specific. Cell 122, 247–260 (2005).
49. Karttunen, J., Sanderson, S. & Shastri, N. Detection of rare antigen-
presenting cells by the lacZ T-cell activation assay suggests an expression
cloning strategy for T-cell antigens. Proc. Natl Acad. Sci. USA 89,
6020–6024 (1992).
50. Douglas, T., Champagne, C., Morizot, A., Lapointe, J. M. & Saleh, M. The
inflammatory caspases-1 and -11 mediate the pathogenesis of dermatitis in
sharpin-deficient mice. J. Immunol. 195, 2365–2373 (2015).
Acknowledgements
We thank the Anatomic Pathology Center of the Graduate School of Medicine, Kyoto
University, for preparing tissue sections. We also thank Sho Hanakawa, Kenji Kaba-
shima, Miho Sekai, Yoko Hamazaki, Nagahiro Minato (Kyoto University, Japan), and
Alexander Rudensky (Memorial Sloan Kettering Cancer Center, USA) for help with
generating mutant mice. We would like to thank Eric Huseby (University of Massa-
chusetts Medical School, MA, USA), Nilabh Shastri (University of California, USA),
Yoshinori Fukui (Kyushu University, Japan), and Takayuki Kanaseki (Sapporo Medical
University, Japan) for providing the cell lines. Finally, we thank all members of Kazuhiro
Iwai’s lab for technical support and discussion. This work was supported by JSPS
KAKENHI Grant Numbers 24112002, 25253019, 26670154, 17H06174, and 18H05499
(to K.I.) and 16K19106 (to K.S.).
Author contributions
K.S. and K.I. designed the experiments, interpreted the results, and wrote the paper. K.S.
performed the experiments. A.H. and T.N. performed flow cytometry analysis. Y.S. and
K.I. generated conditional HOIP and Sharpin knockout mice. H.K. generated conditional
Sharpin transgenic mice.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11858-7 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:3878 | https://doi.org/10.1038/s41467-019-11858-7 | www.nature.com/naturecommunications 15
Additional information
Supplementary Information accompanies this paper at https://doi.org/10.1038/s41467-
019-11858-7.
Competing interests: The authors declare no competing interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
Peer review information: Nature Communications thanks Thomas Kupper, Shao-Cong
Sun and other anonymous reviewer(s) for their contribution to the peer review of this
work. Peer reviewer reports are available.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2019
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11858-7
16 NATURE COMMUNICATIONS |         (2019) 10:3878 | https://doi.org/10.1038/s41467-019-11858-7 | www.nature.com/naturecommunications
